Skip to content

Analgesic efficacy of celecoxib 400mg in patients after oral surgery

Analgesic efficacy of celecoxib 400mg in patients after oral surgery - Analgesic efficacy of celecoxib 400mg in patients after oral surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013503
Enrollment
100
Registered
2014-03-25
Start date
2013-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental pain after mandibular 3rd molar extraction surgery

Interventions

celecoxib

Sponsors

Tokai University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The eligible subjects are patients who will undergo surgical extraction of mandiblar 3rd molar, and need analgesic medication for the treatment of postsurgical pain

Exclusion criteria

Exclusion criteria: Patients as below are excluded 1. with concomitant use of other analgesics before or on the day of surgery 2. undergo surgery with general anesthesia 3. with severe cardiac disease, nephropathy, liver disease, hematologic disease, or hypertension 4. with hypersensitivity to celecoxib 5. with gastrointestinal hemorrhages, or ulcers 6. with aspirin-induced asthma, or the past history 7. if they were pregnant, breastfeeding, with potential pregnancy, or willing to be pregnant during the study 8. inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
magnitude of pain relief

Secondary

MeasureTime frame
patient impression of pain relief onset of pain relief changes in pain (VAS score) use of rescue medication

Countries

Japan

Contacts

Public ContactYoshihide Ota

Tokai University School of Medicine Department of Oral and Maxillofacial Surgery

yotaorsg@yahoo.co.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026